Diethyl pyrocarbonate (DEPC) in conditions that favour carbethoxylation of histidyl residues strongly inactivated E-type ATPase activity of a rat lung membrane preparation, as well as ecto-ATPase activity of rat vessels and human Epstein^Barr virus-transformed B lymphocytes. Inactivation of the enzyme (up to 70%) achieved at concentrations of DEPC below 0.5 mM could be fully reversed by 200 mM hydroxylamine at pH 7.5, thus confirming histidine-selective modification. UTP effectively protected the enzyme activity from DEPC inactivation. This was taken to indicate that the conformation adopted by the enzyme molecule upon substrate binding was not compatible with DEPC reaching and/or modifying the relevant histidyl residue. Substrate activation curves were interpreted to show the enzyme molecule to be inactive, at all substrate concentrations tested, when the target histidyl residue had been modified by DEPC. Comparison of known sequences of CD39-like ecto-ATP(D)ases with the results on inactivation by DEPC revealed His-59 and His-251 (according to the human CD39 sequence) as equally possible targets of the inactivating DEPC modification. Potato apyrase lacks a homologue for the former residue, while the latter is preserved in the enzyme sequence. Therefore, this enzyme was exposed to DEPC, and since hydrolysis of ATP and ADP by potato apyrase was insensitive to modification with DEPC, it was concluded that His-59 is the essential residue in CD39 that is affected by DEPC modification in a way that causes inactivation of the enzyme. ß 2000 Elsevier Science B.V. All rights reserved.
Introduction
E-type ATPases are enzymes that hydrolyse phosphoanhydride bonds in various nucleoside tri-and/or diphosphates; they show an obligatory requirement for divalent cations without strict selectivity between Ca 2 and Mg 2 , and they are insensitive to commonly used inhibitors of F-type, P-type and V-type ATPases [1] . Structurally, some of the E-type ATPases originated from mutually unrelated protein families [2^8], but the largest, widely distributed group of these enzymes belongs to the CD39-like family of proteins. Lymphoid cell activation antigen CD39 and potato apyrase are prototypes for membranebound and soluble forms, respectively, of members of this family [2, 9, 10] which includes a broad variety of enzymes expressed from protozoa and plants to mammalians. Membrane-bound forms are found preferentially, but not exclusively, in the plasma membrane, where the catalytic site of the protein is located at the extracellular side. Members of the family di¡er in substrate speci¢city and in ability to hydrolyze nucleoside di-and triphosphates. Some members, like the enzymes from chicken gizzard [11] and rat brain [12] , are ATPases, exhibiting a high selectivity to nucleoside triphosphates only, while e.g. CD39s and potato apyrase are ATP diphosphohydrolases (ATPDases), or apyrases, hydrolysing nucleoside di-and triphosphates almost equally well [9, 13, 14] . Still other members of the family, like the chicken oviduct enzyme [15] and HB6 from human brain [16] , show an intermediate selectivity. It has not yet been unambiguously established how the differences in substrate speci¢city relate to structural di¡erences, but it is noteworthy that cells may coexpress these enzymes [12] , indicating that they may di¡er with respect to function.
Comparison of sequences revealed that CD39-like proteins all contain ¢ve apyrase conserved regions (ACRs) [2, 17, 18] . Analysis of these regions disclosed certain motifs that are conserved also in functionally important regions of proteins that belong to the wellcharacterised actin/hsp70/sugar kinase superfamily [2] . In CD39-like proteins, site-directed mutagenesis of residues with established function in the actin/ hsp70/sugar kinase superfamily is a promising approach to elucidate critical residues and structural elements involved in the enzymatic function [17, 19] . An alternative approach in the search for functionally important regions and residues may be provided by a selective chemical modi¢cation.
Diethyl pyrocarbonate (DEPC) is a widely used tool in chemical modi¢cation of proteins because of the high selectivity of the reagent to histidyl residues [20] . Even though`silent' modi¢cations not a¡ecting the enzymatic function may take place, modi¢cation with DEPC was successfully used in studies of various groups of enzymes, e.g. ribonucleases, proteases and P-type ATPases [20^22] . In studies on various Etype ATPases, inactivation of the enzyme by DEPC was ¢rst demonstrated for rabbit and chicken transverse tubule ATPases, and histidyl residues were suggested as the target of the inactivating modi¢cation [23, 24] . Recently, inactivation of E-type ATPases in cardiac, renal and intestinal rat membranes, as well as in chicken gizzard and liver membranes, has been demonstrated [25, 26] , but sequence information [11] is available for only one of these DEPC-sensitive enzymes [26] . This paper is focused on selecting for DEPC modi¢cation, by search among cell types and species, some CD39-like proteins that contain sequences that may provide information enabling distinction between di¡erent possible targets of the enzyme-inactivating modi¢cation. In this way, human CD39, rat CD39 and potato apyrase were selected. By comparing the inactivation results with the corresponding enzymes' sequences, evidence was obtained indicating that His-59, according to the sequence of human CD39, is the most plausible target of modi¢cation by DEPC. This residue seems to have an important functional signi¢cance in the enzymatic catalysis.
Materials and methods

Materials
RPMI 1640 medium was obtained from Gibco Laboratories, USA, foetal calf serum was from Biological Industries, Israel, [Q-32 P]ATP was from Amersham, isopropanol and extra-pure ethanol were from Merck. All other reagents were supplied by Sigma. Potato apyrase was grade V from Sigma that exhibits hydrolysis of both ATP and ADP.
Enzyme sources
In studies on membrane-bound enzymes, three different well-established experimental systems were used that had in common CD39 expression: (1) Epstein^Barr virus-transformed lymphoblastoid B cells (EBV-B cells) where human CD39 was ¢rst discovered and best characterised [2, 9, 10] , (2) rat lung membranes, and (3) mesenteric small arteries, both enriched in CD39, and the latter allowing repeated treatment and assay of the same material. EBVtransformed lymphoblastoid cells JY were grown in a RPMI 1640 medium supplemented with 10% heatinactivated foetal calf serum and antibiotics, and used in the logarithmic phase of growth. Before ex-periments, the cells were sedimented at 500Ug for 7 min and washed twice in a 5-fold volume of a medium, HB, consisting of (mM): N-(2-hydroxyethyl)-piperazine-NP-2-ethanesulfonic acid (HEPES) 20, glucose 10, NaCl 150, CaCl 2 2, pH 7.5.
Rat mesenterium was isolated from male Wistar rats and placed in ice-cold physiological salt solution, PSS, pH 7.5, containing, mM: HEPES 5, NaCl 120, KCl 4.6, KH 2 PO 4 1.2, MgSO 4 1.2, EDTA 0.026, NaHCO 3 25, glucose 5.5 and CaCl 2 2.5. Segments of vessels were dissected free of fat and connective tissue. Before incubation and assay of ecto-ATPase activity in PSS, the segments were weighted [27, 28] .
The post-mitochondrial membrane fraction from rat lungs was isolated from tissue, homogenised in 30 mM histidine, pH 7.4, containing 7.7% sucrose and 0.1 mM EDTA, by di¡erential centrifugation (at 10 000Ug for 15 min and centrifugation of the supernatant at 100 000Ug for 1 h). The resulting pellet was resuspended in the same solution, but histidine was replaced with HEPES, 30 mM, and the speci¢c activity determined to be 4.6 U per mg of protein. Protein was measured according to the Coomassie brilliant blue technique [29] using BSA as a standard.
Modi¢cation by DEPC
Serial dilutions of DEPC were prepared in dry ethanol and the actual DEPC concentration was determined by reaction with 10 mM imidazole [20] . EBV-B cell samples, suspended in HB, were placed on ice for 5 min, and DEPC in ethanol or ethanol alone (5% ¢nal concentration) was added to the samples. After 20^30 min at 4³C, the modi¢cation was terminated by adding a 5-fold molar excess over DEPC of histidine bu¡er, pH 7.5. The concentration of cells during DEPC treatment was 2.5^5U10 5 cells/ ml. When DEPC modi¢cation in the presence or absence of 2.5 mM UTP was compared, more dilute samples (2U10 5 cells in 2 ml of HB) were used, so that the decrease in substrate concentration due to enzymatic hydrolysis did not exceed 5%. After modi¢cation, samples were washed twice with HB. When studying the pH-dependence of DEPC inactivation, cells were washed in HB bu¡er adjusted to pH 6.0, 6.5, 7.0 or 7.5, suspended in HB of the corresponding pH and DEPC modi¢cation was performed as above. Reversal of DEPC inactivation was studied using EBV-B cells modi¢ed at pH 7.5. After washing and resuspending in HB, the cells were treated with 200 mM hydroxylamine, added from a 1 M stock solution of hydroxylamine in HB, adjusted to pH 7.5. The mixture was incubated at 4³C for 10^30 min, diluted 5-fold by HB, and cells were sedimented and washed, as above. Rat artery segments were treated with DEPC in PSS at 4³C for 30 min, and the rat lung membrane preparation was modi¢ed under the same conditions, but in HEPES bu¡er (30 mM, pH 7.4), and the protein concentration during modi¢cation was 43 Wg/ml. The control and the modi¢ed membrane preparations were diluted 1000 times in the assay. In the experiment (Fig. 6) showing protection by UTP from DEPC inactivation, 2.5 nmol of UTP was added to each assay with the enzyme source. This could be taken into account calculating the concentration and the speci¢c radioactivity of the combined substrate, ATP and UTP, since it was shown [30] that both nucleotides serve equally well as substrates for the rat lung enzyme. Potato apyrase was dialysed against HB prior to DEPC modi¢cation.
Determination of nucleotide hydrolytic activity
Ecto-ATPase activity of EBV-B cells and rat mesenteric arteries, as well as E-type ATPase activity of the rat lung membrane fraction were determined as the rate of enzymatic P i release from nucleoside trior diphosphate. Control and DEPC-treated EBV-B cells were suspended in HB. Aliquots were drawn for cell counting in a Coulter Multisizer II (Counter Electronics, Northwell Drive, UK). Routinely, the standard assay was performed in 96-well plates for tissue cell culture (Greiner). Duplicate samples of 0.05^0.1 ml of cell suspension (10 4 cells) were added to preheated HB containing sodium orthovanadate, oligomycin and ATP, so that the ¢nal concentrations in the assay were 0.1 mM, 10 WM and 1 mM, respectively, in 0.3 ml total volume. Plates were covered by a plate sealer and incubated in a water bath at 37³C during 15^30 min. The reaction was terminated by placing the plate on ice and adding 30 Wl 6 N H 2 SO 4 . Samples were centrifuged for 3 min at 400Ug, and the amount of P i released from ATP was determined in the supernatants using two colourimetric procedures of di¡erent sensitivity [31, 32] , modi¢ed as described previously [4] . Two values, non-enzymatic P i release from ATP into the assay medium during incubation without cells and the P i content in samples incubated without ATP, were subtracted from the total P i release giving values for the enzymatic ATP hydrolysis. KH 2 PO 4 was used as a standard. EctoATPase activity of the EBV-B cells (in a logarithmic phase of growth) was 67 þ 14 mU/10 6 cells. The assay for ADP hydrolysis contained additionally 0.2 mM diadenosine pentaphosphate. The actual concentrations of all nucleoside di-and triphosphates were determined spectrophotometrically, and the enzymatic hydrolysis of ADP, GTP, CTP and UTP was measured according to the procedure described for ATP.
For measuring the ecto-ATPase activity of rat small mesenteric artery, each segment of rat mesenteric artery (average weight 2 mg per segment) was preincubated at 37³C for 2 min in 450 Wl of PSS. Fifty Wl of 10 mM [
32 P]ATP (speci¢c activity 600 cpm per nmol) was added, and hydrolysis allowed to proceed at 37³C for 10 min. At the end of the assay, the segment was removed/transferred and the incubation medium placed on ice. Upon the addition of 50 Wl of ice-cold 50% TCA, 32 P i was extracted and determined according to [33] . Corresponding to each set of conditions, [ 32 P]ATP hydrolysis was measured in incubations without vessel and the value subtracted as blank [27, 28] . Average ecto-ATPase activity was 3.9 U/g of tissue.
The E-type ATPase activity of rat lung membrane preparation was measured in an assay volume of 0.5 ml, and the assay medium consisted of, WM: Mg 2 2, sodium orthovanadate 50, oligomycin 6, NEM 500 and levamisole 1000, in 30 mM HEPES bu¡er (pH 7.4 at 37³C) with 20 mM of NaCl. After 10 min at 37³C, the reaction was stopped adding 50 Wl of icecold 50% TCA on ice, and released P i was determined according to [33] . In the standard assay ( Fig.  2 
Results
The ecto-ATPase activity of rat small mesenteric arteries was previously characterised in details [27, 28] . The enzyme belongs to the CD39 family [34] .
In Fig. 1 are shown the results obtained when the ecto-ATPDase of rat small arteries was modi¢ed by DEPC. This enzyme source enables a quantitative transfer, repeated treatment and repeated assay of the same material: the ecto-ATPase activity of nine segments was determined (¢rst assay), and in the following 30 min, three segments (group A) were incubated with DEPC (0.5 mM), while six segments (group B and C) were incubated as control, at 4³C. At the end of the incubation, each of the nine segments was assayed again (second assay). During the next 30 min, another three segments (group B) were incubated with DEPC (0.5 mM), while the six segments in group A and C were incubated as control, Fig. 1 . Inactivation of ecto-ATPase activity of mesenteric artery segments by DEPC modi¢cation. The ecto-ATPase activity of nine segments was determined in PSS with 1 mM [Q-
32 P]ATP (1st assay), and in the following 30 min, three segments (group A, R) were incubated with DEPC (0.5 mM) in PSS, while six segments (group B, b, and C, F) were incubated as control, at 4³C. At the end of the incubation, each of the nine segments was assayed again (2nd assay). During the next 30 min, another three segments (group B) were incubated with DEPC (0.5 mM), while the six segments in group A and C were incubated as control, at 4³C. Finally, all nine segments were submitted to the 3rd assay of ecto-ATPase activity. Corresponding to each transfer, from assay to incubation and back, the segments were thoroughly rinsed in PSS. Remaining ecto-ATPase activity in the 2nd and 3rd assay is expressed as percent of the activity measured in the 1st assay of the individual segment. (The mean of the latter value was 3.9 U/g of tissue).
at 4³C. Finally, all nine segments were submitted to the third assay of ecto-ATPase activity. Corresponding to each transfer, from assay to incubation and back, the segments were thoroughly rinsed in PSS. Remaining ecto-ATPase activity in the second and third assay is expressed as percent of the activity measured in the ¢rst assay of the individual segment. (The mean of the latter value was 3.9 U/g of tissue). The decline in ecto-ATPase activity in the controls (group B: between ¢rst and second assay, and group C: between ¢rst and second and between second and third assay) is caused by substrate inactivation during the assay period(s) [1, 27] . DEPC treatment of group A resulted in a strong decrease in the enzymatic activity to 13% of the initial level, while the control vessels (groups B and C) retained 83% of the initial ecto-ATPase activity. Thus, in comparison to the control, activity dropped to 15.7%. After DEPC treatment of group B, the ecto-ATPase activity was reduced to 7% of the initial level, or to 11% if compared to the control (group C) that fell to 65% of the initial level of activity. No recovery of the enzymatic activity (between second and third assay) could be observed in the vessels of group A, indicating that the modi¢cation was stable and recycling of the enzyme was not observed. Thus, DEPC modi¢cation strongly inactivates ecto-ATPase activity of rat mesenteric small arteries, and the degree of substrate-dependent inactivation, that precedes DEPC-treatment, does not seem to in£uence the sensitivity of the enzyme to DEPC inactivation.
CD39/ecto-ATPDase was ¢rst discovered in EBV-B cells, where it was characterised as the only enzyme hydrolysing extracellular ATP [9] . In Fig. 2 are shown the results of DEPC modi¢cation of these cells, as well as of rat lung membranes, known to highly express CD39 [12, 34] . The ecto-ATPase activity of EBV-B cells and the E-type ATPase activity of rat lung membranes are inactivated to the same extent by DEPC (Fig. 2) , and the sensitivity of these enzymes to DEPC is comparable with that of the enzyme in rat mesenteric small arteries (Fig. 1) . Since CD39 is capable of hydrolysing various nucleoside di-and triphosphates, we next tested the substrate speci¢city of DEPC-inactivated CD39 (Fig. 3) . Modi¢cation by DEPC, terminated by excess of histidine, led to inactivation of all the enzymatic activities of CD39 in EBV-B cells: ADP hydrolysis was reduced to the same extent as ATP hydrolysis, but the hydrolysis of pyrimidine nucleoside triphosphates was suppressed by DEPC modi¢cation slightly more than hydrolysis of purine nucleoside triphosphates (Fig.  3) .
DEPC has a high selectivity to histidyl residues, but it is capable of modifying also tyrosyl, lysyl, arginyl and cysteinyl residues [20] . Two criteria are commonly used to distinguish between the possible target residues [20] : (1) the pH-dependence of the modi¢cation: this is determined by pK of the side chain group of the residue, and (2) reversibility of the modi¢cation by treatment with hydroxylamine, which is rapid in the case of carbethoxylated histidyl, but is also possible if a tyrosyl residue is modi¢ed. Fig. 4a shows the relationship between DEPC inactivation of ecto-ATPase in EBV-B cells and pH during DEPC modi¢cation. At all tested pH values, the inactivation follows a single exponential dependence on the concentration of the modifying reagent, and the obtained pH pro¢le is most consistent with carbethoxylation of the imidazole group in histidyl residue [20] as has been proposed formerly [23, 24, 26 ]. This conclusion is further supported by the rapid reversibility of the enzyme inactivation upon treatment with 200 mM hydroxylamine, consistent with decarbethoxylation of modi¢ed histidyl residues (Fig.  4b) . At low DEPC concentrations, recovery of the enzymatic activity is almost complete in 10 min if compared to the activity of control EBV-B cells treated only with 200 mM hydroxylamine. Restoration was 82% and 76% for the preparations modi¢ed with 1 mM and 2 mM DEPC, respectively (Fig. 4b) . Recovery of the enzymatic activity did not increase if the treatment with hydroxylamine was extended to 30 min (not shown). Incomplete recovery of the activity could be the result of a concomitant modi¢ca-tion of another, not histidyl, target residue. The increase in the fraction of irreversibly inactivated ATPase with increase in DEPC concentration may, however, alternatively point to a formation of a disubstituted histidyl derivative. Such a compound is known to be insensitive to treatment with hydroxylamine [20] .
Inactivation of the ecto-ATPase activity in EBV-B cells could be prevented if the substrate of the enzyme was present during DEPC treatment (Fig. 5) . In the presence of 2.5 mM UTP, protection of the enzyme was observed at all DEPC concentrations tested, but protection was most e¡ective at a higher ratio of substrate over modi¢er concentration. Thus, while more than half of the enzymatic activity was lost during modi¢cation with 0.2 mM DEPC alone, inactivation was prevented almost completely by the presence of 2.5 mM UTP during DEPC treatment (Fig. 5) . In rat mesenteric small vessels, the presence of substrate (UTP) prevented inactivation of the ecto-ATPDase by DEPC (not shown), but since the presence of substrate alone causes inactivation of the enzyme (decreased substrate a¤nity) in intact rat vessels [27] , the interpretation of these experiments is di¤cult. Protection from DEPC inactivation of E-type ATPase activity of rat lung membranes could be demonstrated (Fig. 6) , and also in this enzyme source was the protective e¡ect dependent on the ratio between substrate and modi¢er concentration (not shown). Since pyrimidine nucleotides, unlike purines [20] , do not react directly with DEPC, it is binding of the substrate to the enzyme that prevents modi¢cation of a functionally essential histidyl residue due to a steric hindrance or a conformational transition in the protein, which a¡ects either reactivity or accessibility of the target. Fig. 6 shows double reciprocal plots for E-type ATPase of rat lung membranes in control preparations and preparations modi¢ed by DEPC in the absence or presence of UTP. After modi¢cation, samples were 1000-fold diluted in the assay where ATPase activity was determined by measuring radioactive phosphate release from [Q-32 P]ATP, keeping an equimolar ratio of Ca and ATP over a broad range of substrate concentrations. DEPC modi¢cation decreased the maximal velocity of ATP hydrolysis, and the presence of UTP during DEPC treatment prevented this inactivation of the enzyme (Fig. 6) . A decrease in the maximal velocity was obtained also when comparing hydrolysis of UTP by ecto-ATPase of DEPC-modi¢ed and control EBV-B cells (not shown). The observed kinetic patterns are compatible with an impaired catalytic step or complete inactivation of the part of the molecules, while non-modi¢ed molecules bind and hydrolyse substrate as before [35] .
Search for a possible target of DEPC modi¢cation should focus on histidyl residues conserved in the CD39 family of proteins, and comparison of sequences of membrane-bound and soluble members revealed only ¢ve conserved histidyl residues to be considered. The regions of the polypeptide chains, which include these conserved histidyl residues, are presented in Table 1 . The conserved histidyl residue found closest to the C-terminal, His-474, is preserved only in all CD39s, but not in other enzymes belonging to the CD39 family of proteins. Since chicken gizzard ecto-ATPase lacks this residue, and since DEPC was shown to inactivate this enzyme activity [26] , His-474 could not be the target of the inactivating modi¢cation. For the same reason, His-438 could be excluded, and His-121 was discarded as a possible candidate, since this residue is absent in rat CD39 and chicken oviduct ATPDase, and since the former enzyme was shown to be DEPC-sensitive in the present work. The remaining two conserved histidyl residues were His-251, found in all the discussed sequences (Table 1) , and His-59, that is missing in HB6 and potato apyrase.
Thus, the sensitivity of potato apyrase to DEPC Fig. 6 . Double reciprocal plots of substrate curves of the Etype ATPase activity of rat lung membranes. Control preparations (F), enzyme-treated with 0.2 mM DEPC (R) and enzymetreated with 0.2 mM DEPC in the presence of 5 mM UTP (P). In the latter case, 2.5 nmol of UTP was added to each assay with the enzyme source. This was taken into account calculating the concentration and the speci¢c radioactivity of the combined substrates ATP and UTP. inactivation was used to distinguish between His-59 and His-251 as possible targets of DEPC inactivation. As shown in Fig. 7 , there is a drastic di¡erence between the enzymatic activities of human CD39 and potato apyrase in their sensitivity to DEPC inactivation. In control experiments, stabilisation of CD39 oligomers in EBV-B cells by cross-linking at pH 8.8 with 10 mM dimethyl pimelimidate [4] , either in the absence or the presence of ATP, did not result in the occurrence of a DEPC-insensitive fraction of ectoATPDase (not shown). Since the ATPase and the ADPase activity of potato apyrase were insensitive to DEPC modi¢cation, this points to His-59 as the most likely target of DEPC inactivation.
Discussion
Identi¢cation of residues that are essential for the catalytic function of CD39-like proteins contributes importantly to the elucidation of the underlying reaction mechanism. Recent cloning and sequencing of a number of these proteins has led to the discovery in their structure of certain motifs conserved in members of the actin/hsp70/sugar kinase superfamily [2, 17] . Functional knowledge about residues in these motifs was used to select targets for site-directed mutagenesis [19] . In the present work, inactivation of the enzymes caused by chemical modi¢cation by DEPC was analysed in the context of known primary structure and used as an independent alternative approach to search for regions and residues that are functionally important among CD39-like proteins, while not obligatorily conserved among other members of the superfamily. DEPC modi¢cations of human CD39, rat CD39 and potato apyrase were evaluated in the perspective of previous studies [23, 24, 26] Alignment was performed using the ClustalW program. The sequences and GenBank accession numbers are, respectively, human CD39, S73813; rat CD39, U81295; murine CD39, AF037366; bovine CD39, AF005940 ; human CD39L1, U91510; rat brain ectoATPase, Y11835; chicken gizzard ecto-ATPase; U74467, chicken oviduct ecto-ATPDase, AF041355; human HB6, AF034840; and potato apyrase, U58597. The numbers on the right side of each of ¢ve columns indicate numbers of the C-terminal residue of the fragment in each of the individual sequences. leading to the conclusion that the target of inactivating DEPC modi¢cation is His-59 in human CD39 and homologous residues in other CD39-like E-type ATPases. First, inactivation by DEPC of the enzyme in rat mesenteric small arteries, rat lung membranes and in human EBV-B cells was demonstrated (Figs. 1 and  2) . It was further shown that all the enzymatic activities expressed by CD39 were inactivated by DEPC modi¢cation (Fig. 3) . Characteristics of DEPC inactivation, pH pro¢le and reversibility by hydroxylamine treatment (Fig. 4a,b) , indicated that the inactivating DEPC modi¢cation resulted in carbethoxylation of histidyl residue(s), as has been proposed previously for some other E-type ATPases [23, 24, 26] . Next, it was shown that the presence of the substrate, UTP, protected the enzyme from DEPC inactivation (Figs. 5 and 6 ). ATP may react directly with DEPC [20] , and the protective e¡ect of this substrate [23, 26] could be caused by a decrease in the actual DEPC concentration in the presence of ATP. But the choice of a pyrimidine substrate eliminated this possibility, and the protective e¡ect of UTP against DEPC inactivation (Figs. 5 and 6) indicated that a region of the enzyme containing a critical histidyl residue was protected from DEPC by substrate binding, possibly because the binding of substrate was followed by a local function-associated conformational transition that prevented DEPC modi¢cation of the target residue. On the other hand, when the target histidyl residue was modi¢ed by DEPC, the enzyme molecule became inactive. The introduction of an additional bulky side group probably represented a steric disadvantage that prevented either substrate binding or a conformational transition involved in catalysis, or both. It is consistent with the decrease in maximal velocity seen in Fig. 6 that a fraction of the enzyme molecules had become inactive, the rest catalysing the hydrolysis of the substrate as usual. Increasing the substrate concentration did not change the proportion between the two fractions (Fig. 6) .
Search for the residue critical for DEPC inactivation (by comparing sequences of CD39-like proteins and the corresponding DEPC sensitivity) led us to conclude that the most probable target of DEPC inactivation is the conserved His-59, according to the sequence of human CD39. It is noteworthy that this essential target residue is localised within ACR1, i.e. one of the two ACR sequences that are conserved in the actin/hsp70/sugar kinase superfamily [2] . The functional signi¢cance of ACR1 and two residues within this region, homologous to Asp-54 and Gly-56 in CD39, has been demonstrated by deletions and site-directed mutagenesis in human CD39 and in HB6, respectively [17, 19] . Furthermore, these two amino acid residues that are both present in the L-phosphate binding motif of all members of the actin/hsp70/sugar kinase superfamily were shown to participate in the enzymatic catalysis in various members of the superfamily [19, 36] . The inactivation of CD39 by modi¢cation of His-59, localised in close proximity to these two critical residues, demonstrates further the functional signi¢cance of ACR1.
In one of the membrane-bound CD39-like ectoATPases, HB6, His at this position is substituted by Arg [16] . This may indicate that either the residue, even though being part of the sequence in the catalytic region, is not functionally signi¢cant, and DEPC modi¢cation inactivates the enzyme solely because of steric factors, or that the function carried by the residue at this position tolerates some substitutions. Noteworthy, only HB6 sequence contains a histidyl residue (marked in bold in Table 1 ) in a very conserved part of ACR2. Since the ACRs are assumed to be in a close proximity in the tertiary structure [2] , this histidyl could be a structural^func-tional substitution for histidyl residue lacking in ACR1 of HB6. Chemical modi¢cation data do not prove directly functional signi¢cance and the role of the particular target of the modi¢cation, but a possible function can be suggested based on conservation of the residue in a number of related sequences, as well as by analogy with similar proteins. There are two functionally important histidyl residues in the structure of actin [36] . One of them, His-73, is located close to ACR1 and, according to atomic structure data, it occupies a position where it participates in the enzymatic catalysis by coordinating the water molecule that attacks the Q-phosphate of ATP during the enzymatic catalysis [36] . In hsp70, the same position is occupied and the same function undertaken by Lys-71 [36] , indicating no strict requirement for His in the speci¢c function. Potato apyrase is DEPCinsensitive (Fig. 7) . This enzyme contains Gly (Table  1) at the position homologous to His-59 in the CD39 sequence. If by analogy with actin [36] , His-59 has a functional signi¢cance in E-type ATPases, (1) this function can tolerate some amino acid substitutions, less dramatic than introducing a hydrophobic carbethoxy group into His; (2) structural limitations or requirements put on the enzyme by this function (which could be, for example, coordination of the water molecule attacking Q-phosphate) may di¡er for highly organised membrane-bound oligomer and soluble monomeric enzyme.
In conclusion, His-59 in the sequence of CD39 and homologous sequences in CD39-like proteins is the most probable target for inactivation by DEPC. Further studies are required to elucidate the molecular mechanism behind the inactivation and roles for this histidyl residue in the enzymatic function of E-type ATPases. 
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